Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Sep;41(9):1933–1936. doi: 10.1128/aac.41.9.1933

Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice.

H Thadepalli 1, S K Chuah 1, U Reddy 1, N Hanna 1, R Clark 1, R J Polzer 1, S Gollapudi 1
PMCID: PMC164038  PMID: 9303387

Abstract

We investigated the efficacy of trovafloxacin, a new quinolone, in comparison with that of clindamycin in the treatment of intra-abdominal abscesses caused by Bacteroides fragilis in young and senescent mice. The development of abscess formation, the number of viable organisms, and antibiotic concentrations were measured, and the values for young and old mice were compared. Trovafloxacin was well distributed to the tissues in both young and old animals. Although the pharmacokinetics and concentrations of trovafloxacin in serum were similar between young and old mice, the levels in tissue were higher in senescent mice than in young mice. Trovafloxacin therapy sterilized abscesses in 94% of young mice and in 73% of old mice, but this difference was not significant. This therapeutic response to trovafloxacin was similar to that seen with clindamycin. These results suggest that aging may not have any adverse effect on the therapeutic outcome for intra-abdominal abscesses caused by B. fragilis.

Full Text

The Full Text of this article is available as a PDF (196.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook I. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities. Antimicrob Agents Chemother. 1993 May;37(5):997–1000. doi: 10.1128/aac.37.5.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gardner I. D., Remington J. S. Age-related decline in the resistance of mice to infection with intracellular pathogens. Infect Immun. 1977 May;16(2):593–598. doi: 10.1128/iai.16.2.593-598.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Girard A. E., Girard D., Gootz T. D., Faiella J. A., Cimochowski C. R. In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis. Antimicrob Agents Chemother. 1995 Oct;39(10):2210–2216. doi: 10.1128/aac.39.10.2210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gleckman R. A. Antibiotic concerns in the elderly. A clinician's perspective. Infect Dis Clin North Am. 1995 Sep;9(3):575–590. [PubMed] [Google Scholar]
  5. Gollapudi S. V., Gupta A., Thadepalli H., Perez A. Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis. Infect Immun. 1988 Sep;56(9):2369–2372. doi: 10.1128/iai.56.9.2369-2372.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lewis D. A., Reeves D. S. Antibiotics at the extremes of age: choices and constraints. J Antimicrob Chemother. 1994 Aug;34 (Suppl A):11–18. doi: 10.1093/jac/34.suppl_a.11. [DOI] [PubMed] [Google Scholar]
  7. Louria D. B., Sen P., Buse M. Age-dependent differences in outcome of infections, with special reference to experiments in mice. J Am Geriatr Soc. 1982 Dec;30(12):769–773. doi: 10.1111/j.1532-5415.1982.tb03368.x. [DOI] [PubMed] [Google Scholar]
  8. Menon M., Jaroslow R. N., Koesterer R. The decline of cell-mediated immunity in aging mice. J Gerontol. 1974 Sep;29(5):499–505. doi: 10.1093/geronj/29.5.499. [DOI] [PubMed] [Google Scholar]
  9. Owens B. J., Hamit H. F. Appendicitis in the elderly. Ann Surg. 1978 Apr;187(4):392–396. doi: 10.1097/00000658-197804000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Phair J. P., Kauffman C. A., Bjornson A. Investigation of host defense mechanisms in the aged as determinants of nosocomial colonization and pneumonia. J Reticuloendothel Soc. 1978 May;23(5):397–405. [PubMed] [Google Scholar]
  11. Rattan S. I., Derventzi A. Altered cellular responsiveness during ageing. Bioessays. 1991 Nov;13(11):601–606. doi: 10.1002/bies.950131111. [DOI] [PubMed] [Google Scholar]
  12. Schaefer H. G., Michaelis J. Biopharmaceutical aspects of anti-infective therapy at the extremes of age. J Antimicrob Chemother. 1994 Aug;34 (Suppl A):33–42. doi: 10.1093/jac/34.suppl_a.33. [DOI] [PubMed] [Google Scholar]
  13. Shimokata H., Tobin J. D., Muller D. C., Elahi D., Coon P. J., Andres R. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol. 1989 Mar;44(2):M66–M73. doi: 10.1093/geronj/44.2.m66. [DOI] [PubMed] [Google Scholar]
  14. Spangler S. K., Jacobs M. R., Appelbaum P. C. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob Agents Chemother. 1994 Oct;38(10):2471–2476. doi: 10.1128/aac.38.10.2471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Thadepalli H., Gorbach S. L., Broido P. W., Norsen J., Nyhus L. Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet. 1973 Aug;137(2):270–276. [PubMed] [Google Scholar]
  16. Thadepalli H., Reddy U., Chuah S. K., Thadepalli F., Malilay C., Polzer R. J., Hanna N., Esfandiari A., Brown P., Gollapudi S. In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Antimicrob Agents Chemother. 1997 Mar;41(3):583–586. doi: 10.1128/aac.41.3.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Weinstein W. M., Onderdonk A. B., Bartlett J. G., Gorbach S. L. Experimental intra-abdominal abscesses in rats: development of an experimental model. Infect Immun. 1974 Dec;10(6):1250–1255. doi: 10.1128/iai.10.6.1250-1255.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yoshikawa T. T., Norman D. C. Treatment of infections in elderly patients. Med Clin North Am. 1995 May;79(3):651–661. doi: 10.1016/s0025-7125(16)30061-x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES